RNA Stock Analysis: Buy, Sell, or Hold?
RNA - Avidity Biosciences, Inc. Common Stock
$72.57
0.00 (0.00%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When RNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RNA is currently trading at $72.57, which is considered extended relative to its 30-day fair value range of $72.17 to $72.58.
Technical Outlook: Technically, RNA is in a strong uptrend. The price is currently testing key support at $72.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RNA is in a strong uptrend. The price is currently testing key support at $72.40. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$72.17 -
$72.58
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
45.8%
Protect Your Profits
RNA is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($74.64)
Fair Price Analysis
30-Day Fair Range
$72.17 -
$72.58
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$72.40
Resistance Level
$72.74
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-14.84
Wall Street Target
$74.64
(+2.8%)
Revenue Growth (YoY)
434.0%
Last updated: January 30, 2026 7:45 PM ET
Data refreshes hourly during market hours. Next update: 8:45 PM
Data refreshes hourly during market hours. Next update: 8:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven George Hughes
SELL
2209 shares
2025-10-22
Teresa Mccarthy
SELL
20000 shares
2025-10-15
Eric Mosbrooker
SELL
6562 shares
2025-10-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced RNA Option Strategies
Professional options setups generated by AI based on today's RNA price and gamma walls.
